Format
Sort by
Items per page

Send to

Choose Destination

Best matches for optimal medical therapy AND prevalence AND refractory angina:

Search results

Items: 1 to 20 of 24

1.

Effects of Transendocardial Delivery of Bone Marrow-Derived CD133+ Cells on Left Ventricle Perfusion and Function in Patients With Refractory Angina: Final Results of Randomized, Double-Blinded, Placebo-Controlled REGENT-VSEL Trial.

Wojakowski W, Jadczyk T, Michalewska-Włudarczyk A, Parma Z, Markiewicz M, Rychlik W, Kostkiewicz M, Gruszczyńska K, Błach A, Dzier Zak-Mietła M, Wańha W, Ciosek J, Ochała B, Rzeszutko Ł, Cybulski W, Partyka Ł, Zasada W, Włudarczyk W, Dworowy S, Kuczmik W, Smolka G, Pawłowski T, Ochała A, Tendera M.

Circ Res. 2017 Feb 17;120(4):670-680. doi: 10.1161/CIRCRESAHA.116.309009. Epub 2016 Nov 30.

PMID:
27903568
2.

A prospective study of patients with refractory angina: outcomes and the role of high-sensitivity troponin T.

Poppi NT, Gowdak LH, Dourado LO, Adam EL, Leite TN, Mioto BM, Krieger JE, César LA, Pereira AC.

Clin Cardiol. 2017 Jan;40(1):11-17. doi: 10.1002/clc.22599. Epub 2016 Oct 18.

3.

[Coronary Sinus Reducer implantation: a new treatment for chronic refractory angina].

Giannini F, Aurelio A, Chieffo A.

G Ital Cardiol (Rome). 2016 Oct;17(10 Suppl 1):3S-9. doi: 10.1714/2372.25470. Italian.

PMID:
27729662
4.

Coronary Sinus Reducer system™: A new therapeutic option in refractory angina patients unsuitable for revascularization.

Ielasi A, Todaro MC, Grigis G, Tespili M.

Int J Cardiol. 2016 Apr 15;209:122-30. doi: 10.1016/j.ijcard.2016.02.018. Epub 2016 Feb 3. Review.

PMID:
26889595
5.

Predictors of Medical Management in Patients Undergoing Elective Cardiac Catheterization for Chronic Ischemic Heart Disease.

Atreya AR, Sivalingam SK, Arora S, Kashef MA, Fitzgerald J, Visintainer P, Lotfi A, Rothberg MB.

Clin Cardiol. 2016 Apr;39(4):207-14. doi: 10.1002/clc.22510. Epub 2016 Feb 5.

6.

Medical Therapy With Versus Without Revascularization in Stable Patients With Moderate and Severe Ischemia: The Case for Community Equipoise.

Stone GW, Hochman JS, Williams DO, Boden WE, Ferguson TB Jr, Harrington RA, Maron DJ.

J Am Coll Cardiol. 2016 Jan 5;67(1):81-99. doi: 10.1016/j.jacc.2015.09.056. Epub 2015 Nov 23. Review.

7.

Transmyocardial laser revascularization versus medical therapy for refractory angina.

Briones E, Lacalle JR, Marin-Leon I, Rueda JR.

Cochrane Database Syst Rev. 2015 Feb 27;(2):CD003712. doi: 10.1002/14651858.CD003712.pub3. Review.

PMID:
25721946
8.

OSA and depression are common and independently associated with refractory angina in patients with coronary artery disease.

Geovanini GR, Gowdak LHW, Pereira AC, Danzi-Soares NJ, Dourado LOC, Poppi NT, Cesar LAM, Drager LF, Lorenzi-Filho G.

Chest. 2014 Jul;146(1):73-80. doi: 10.1378/chest.13-2885.

PMID:
24811214
9.

Noninvasive therapy for the management of patients with advanced coronary artery disease.

Kazmi WH, Rasheed SZ, Ahmed S, Saadat M, Altaf S, Samad A.

Coron Artery Dis. 2012 Dec;23(8):549-54. doi: 10.1097/MCA.0b013e328358a606.

PMID:
23011412
10.

Percutaneous coronary intervention with optimal medical therapy vs. optimal medical therapy alone for patients with stable angina pectoris.

Gorenoi V, Schönermark MP, Hagen A.

GMS Health Technol Assess. 2011;7:Doc07. doi: 10.3205/hta000098. Epub 2011 Nov 10.

11.

Effectiveness of percutaneous laser revascularization therapy for refractory angina.

McGillion M, Cook A, Victor JC, Carroll S, Weston J, Teoh K, Arthur HM.

Vasc Health Risk Manag. 2010 Sep 7;6:735-47. Review.

12.

Transmyocardial laser revascularization versus medical therapy for refractory angina.

Briones E, Lacalle JR, Marin I.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD003712. doi: 10.1002/14651858.CD003712.pub2. Review. Update in: Cochrane Database Syst Rev. 2015;2:CD003712.

PMID:
19160223
13.

Differences in the management and prognosis of women and men who suffer from acute coronary syndromes.

Anand SS, Xie CC, Mehta S, Franzosi MG, Joyner C, Chrolavicius S, Fox KA, Yusuf S; CURE Investigators.

J Am Coll Cardiol. 2005 Nov 15;46(10):1845-51. Epub 2005 Oct 24.

14.

[The problem of chronic refractory angina pectoris].

Chumburidze VB, Kharchilava NA, Aladashvili AV.

Georgian Med News. 2005 Jan;(118):26-8. Russian.

PMID:
15821320
15.

Current medical management of chronic stable angina.

Thadani U.

J Cardiovasc Pharmacol Ther. 2004 Sep;9 Suppl 1:S11-29; quiz S98-9. Review.

PMID:
15378129
16.

Usefulness and safety of percutaneous myocardial laser revascularization for refractory angina pectoris.

Salem M, Rotevatn S, Stavnes S, Brekke M, Vollset SE, Nordrehaug JE.

Am J Cardiol. 2004 May 1;93(9):1086-91.

PMID:
15110197
17.

Enhanced external counterpulsation for ischemic heart disease: what's behind the curtain?

Bonetti PO, Holmes DR Jr, Lerman A, Barsness GW.

J Am Coll Cardiol. 2003 Jun 4;41(11):1918-25. Review.

19.

[Treatment guidelines for refractory angina pectoris now available. Therapeutic methods varying between behavior therapy and heart transplantation].

Eliasson T, Norrsell H, Mannheimer C.

Lakartidningen. 2001 Nov 14;98(46):5170-4, 5176-7. Swedish.

PMID:
11761568
20.

Transmyocardial revascularization with CO2 laser in patients with refractory angina pectoris. Clinical results from the Norwegian randomized trial.

Aaberge L, Nordstrand K, Dragsund M, Saatvedt K, Endresen K, Golf S, Geiran O, Abdelnoor M, Forfang K.

J Am Coll Cardiol. 2000 Apr;35(5):1170-7.

Supplemental Content

Loading ...
Support Center